Fredericton Company Partners with Global Pharmaceutical Provider
Smart Skin Technologies is merging its Quantifeel line monitoring system technology with the Parenteral Drug Association.
Smart Skin Technologies is merging its Quantifeel line monitoring system technology with the Parenteral Drug Association.
New Brunswick’s Smart Skin has quietly scaled to become a vital part of the global beverage and pharmaceutical manufacturing process.
The Fredericton-based company currently supports 18 of the world’s 20 largest pharmaceutical companies and nearly every major bottling company in the world with its Quantifeel solutions.
German technology company SCHOTT is the lead investor for the funding round for Smart Skin, which makes pressure-sensing container devices and analytics used by global brands in beverage, food production and pharmaceutical industries.
They were the only New Brunswick company to make the list.